ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Tumor necrosis factor alpha (TNF-α) inhibitor
Immunoglobulin, anti-(human tumor necrosis factor α) Fab' fragment (human mouse monoclonal CDP870 heavy chain, disulfide bonded with human mouse monoclonal CDP870 light chain), pegylated at Cys-227 on the heavy chain (WHO )
- Certulizumabum pegolum (Latin)
- Certulizumab pegol (German)
- Certulizumab pégol (French)
- Certulizumab pegol (Spanish)
- Certolizumab Pegol (OS: USAN, BAN)
- Certolizumab Pegol (Genetical Recombination) (OS: JAN)
- CDP870 (IS: UCB)
- PHA-738144 (IS)
Biopas, Colombia; Medis Adria, Croatia (Hrvatska); UCB, Australia; UCB, Canada; UCB, Czech Republic; UCB, Denmark; UCB, Finland; UCB, Greece; UCB, Hungary; UCB, Ireland; UCB, Israel; UCB, Lithuania; UCB, Norway; UCB, Poland; UCB, Romania; UCB, Slovakia; UCB, Tunisia; UCB, United States; UCB de Mexico, Mexico; UCB Japan, Japan; UCB Nordic, Sweden; UCB Pharma, Austria; UCB Pharma, Belgium; UCB Pharma, Cyprus; UCB Pharma, Germany; UCB Pharma, Spain; UCB Pharma, France; UCB Pharma, United Kingdom; UCB Pharma, Italy; UCB Pharma, Slovenia; UCB-Pharma, Switzerland
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.